Back


18/01/2017
MINORYX THERAPEUTICS FURTHER STRENGTHENS ITS SCIENTIFIC ADVISORY BOARD (SAB)
Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces that, Dr. Patrick Aubourg, Dr. Marc Engelen, Dr. Florian Eichler and Dr. Gerald Raymond, four renowned clinical experts in X-ALD joined its scientific advisory board  [...]

Download the pdf file





X

X